Virtus ETF Advisers’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-14,044
| Closed | -$72.2K | – | 458 |
|
|
2024
Q1 | $72.2K | Sell |
14,044
-961
| -6% | -$4.94K | 0.04% | 407 |
|
|
2023
Q4 | $86K | Sell |
15,005
-6,353
| -30% | -$36.4K | 0.05% | 413 |
|
|
2023
Q3 | $102K | Sell |
21,358
-2,128
| -9% | -$10.2K | 0.06% | 331 |
|
|
2023
Q2 | $99.8K | Buy |
23,486
+11,087
| +89% | +$47.1K | 0.06% | 381 |
|
|
2023
Q1 | $65.8K | Sell |
12,399
-4,766
| -28% | -$25.3K | 0.04% | 410 |
|
|
2022
Q4 | $108K | Sell |
17,165
-3,204
| -16% | -$20.1K | 0.06% | 436 |
|
|
2022
Q3 | $215K | Buy |
20,369
+154
| +0.8% | +$1.63K | 0.09% | 312 |
|
|
2022
Q2 | $110K | Buy |
20,215
+10,823
| +115% | +$58.9K | 0.04% | 408 |
|
|
2022
Q1 | $86K | Sell |
9,392
-557
| -6% | -$5.1K | 0.04% | 326 |
|
|
2021
Q4 | $150K | Buy |
+9,949
| New | +$150K | 0.06% | 347 |
|